Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    11389303 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Comparative Effectiveness Study Evaluating OROS Methylphenidate HCl, Ritalin (Methylphenidate HCl), and Placebo for the Treatment of Attention Deficit Hyperactivity Disorder in Children
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: Ritalin;   Drug: OROS Methylphenidate HCl;   Drug: Placebo

Indicates status has not been verified in more than two years